Teva asks Supreme court to stay ruling in Copaxone case

WASHINGTON (Reuters) - Teva Pharmaceutical Industries Ltd asked the U.S. Supreme Court on Monday to stop a lower court ruling from going into effect while the justices consider an appeal in a patent fight over Teva's top-selling multiple sclerosis drug Copaxone.

via Reuters: Health News Read More Here..